7MAW
SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM129
Summary for 7MAW
Entry DOI | 10.2210/pdb7maw/pdb |
Descriptor | 3C-like proteinase, ethyl (4R)-4-({3-cyclopropyl-N-[(2E)-3-(4-ethynylphenyl)prop-2-enoyl]-L-alanyl}amino)-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate (3 entities in total) |
Functional Keywords | sars-cov-2, covid-19, covid19 protease, protease inhibitor, covalent inhibitor, complex, hydrolase inhibitor complex, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) |
Total number of polymer chains | 2 |
Total formula weight | 68638.28 |
Authors | Lockbaum, G.J.,Schiffer, C.A. (deposition date: 2021-03-31, release date: 2022-10-12, Last modification date: 2024-10-16) |
Primary citation | Lockbaum, G.J.,Schiffer, C.A. SARS-CoV-2 Main Protease (Mpro) in Complex with Covalent Inhibitor SM129 To Be Published, |
Experimental method | X-RAY DIFFRACTION (2.07 Å) |
Structure validation
Download full validation report